Barclays
OCAT

Barclays’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Barclays’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-219
Closed -$1K – 7143
2015
Q3 		$1K Sell
219
-463
-68% -$2.02K ﹤0.01% 6764
2015
Q2 		$3K Buy
+682
New +$4.37K ﹤0.01% 6755

Other funds holding OCAT

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays's OCAT Position: Q4 2015 in Review

Barclays sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q4 2015, closing a stake of 219 shares — an estimated $1K sold.

Barclays first reported a position in OCAT in Q2 2015 and held it in 2 quarters. The position peaked at $3K in Q2 2015. 77 funds tracked by Wall St. Rank hold OCAT as of Q4 2015.

  • Barclays reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q4 2015 after selling out during the quarter.
  • Barclays sold 219 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q4 2015, an estimated $1K.
  • Barclays first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 2 quarters.
  • Barclays's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $3K in Q2 2015.
  • 77 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q4 2015.

Based on Barclays's 13F filing for Q4 2015, filed 12 Feb 2016.